Cutaneous Oncology News

Female patients with melanoma on immune checkpoint inhibitor therapy exhibited higher rates of dermatologic adverse events compared with male patients, according to a study presented at AAD VMX 2021.

Most adults with sentinel lymph node-positive cutaneous melanoma underwent active ultrasound surveillance rather than surgery across academic medical centers in the U.S., Europe and Australia, according to study results published in Cancer.

Gyorgy Paragh, MD, PhD, has been appointed Lawrence P. & Joan Castellani family chair in dermatology at Roswell Park Comprehensive Cancer Center.

Cutaneous squamous cell carcinomas that were upgraded during Mohs micrographic surgery were more likely to present clinical challenges, according to a study.

More than 80% of patients with heavily pretreated metastatic melanoma experienced tumor shrinkage after receiving the adoptive cell therapy lifileucel, according to results of a phase 2 study.

Tumor mutational burden predicted immune checkpoint inhibitor response among women, but not men, with melanoma, according to findings presented during the virtual American Association for Cancer Research Annual Meeting.

Adults aged over 65 years who took thiazides for hypertension had an increased risk for keratinocyte carcinoma and melanoma, according to results of a population-based cohort study.

Tebentafusp significantly prolonged OS compared with immune checkpoint inhibitors and other standard therapies among previously untreated patients with metastatic uveal melanoma, results of a randomized phase 3 study showed.

Early-stage invasive melanoma excised with Mohs micrographic surgery at academic and top decile-volume facilities was associated with improved long-term survival, according to a study published in JAMA Dermatology.

Cutaneous immune-related adverse events are an early sign of immune-mediated toxic events, and dermatologists can play a role in screening for more severe events, according to a study.